Sökning: onr:"swepub:oai:lup.lub.lu.se:3b5a8885-dd91-4159-a389-0c85ce3dfaec" >
High relapse rate o...
High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden
-
- Kozlowski, Piotr, 1969- (författare)
- Region Örebro län,Hematology Section, Department of Medicine, Örebro University Hospital, Örebro, Sweden
-
- Åström, Maria, 1959- (författare)
- Region Örebro län,Hematology Section, Department of Medicine, Örebro University Hospital, Örebro, Sweden
-
- Ahlberg, Lucia (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Hematologiska kliniken US
-
visa fler...
-
- Bernell, Per (författare)
- Karolinska University Hospital, Stockholm, Sweden
-
- Hulegardh, Erik (författare)
- Department of Hematology and Coagulation, Sahlgrenska University, Göteborg, Sweden
-
- Hägglund, Hans (författare)
- Uppsala universitet,Karolinska Institutet,Hematologi,Karolinska University Hospital, Sweden
-
- Karlsson, Karin (författare)
- Lund University,Lunds universitet,Stamcellscentrum (SCC),Avdelningen för stamcellsforskning,Institutionen för laboratoriemedicin,Medicinska fakulteten,Stem Cell Center,Division of stem cell research,Department of Laboratory Medicine,Faculty of Medicine,Department of Hematology, Skåne University Hospital, Lund, Sweden
-
- Markuszewska-Kuczymska, Alicja (författare)
- Umeå universitet,Onkologi,University Hospital, Sweden
-
- Tomaszewska-Toporska, Beata (författare)
- Department of Hematology, Skåne University Hospital, Lund, Sweden
-
- Smedmyr, Bengt (författare)
- Uppsala universitet,Hematologi,Uppsala University, Sweden
-
- Amini, Rose-Marie (författare)
- Uppsala universitet,Molekylär och morfologisk patologi,Uppsala University, Sweden
-
- Hallböök, Helene (författare)
- Uppsala universitet,Hematologi,Uppsala University, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2014-02-21
- 2014
- Engelska.
-
Ingår i: European Journal of Haematology. - : Wiley. - 1600-0609 .- 0902-4441. ; 92:5, s. 377-381
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://lup.lub.lu.s...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
http://kipublication...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background Hyper-CVAD is widely used to treat acute lymphoblastic leukemia (ALL) and aggressive lymphomas. This multicenter, population-based study assessed the efficacy of Hyper-CVAD as first-line therapy in patients with T-cell ALL (T-ALL). Patients and methods Between October 2002 and September 2006, 24 patients were diagnosed with T-ALL in Sweden; 19 were eligible for treatment with the protocol. Results The median age was 32yr (range 18-72yr). Complete remission (CR) was obtained in 17 of 19 (89%) patients, and the treatment was relatively well tolerated. Allogeneic stem cell transplantation (SCT) was recommended in high-risk disease and was performed in four patients upfront. Two- and 5-yr leukemia-free survivals (LFS) in 17 patients with CR achievement were identical, at 29% (95% confidence interval [CI]: 8-51). Two- and 5-yr overall survival (OS) in whole cohort was 63% (95% CI: 42-85) and 47% (95% CI: 26-69), respectively. The 5-yr LFS for 15 patients who did not receive allogeneic SCT upfront were 20% (95% CI: 0-40), although 14 of 15 completed the protocol (eight cycles). Relapse occurred in 2 of 4 upfront-transplanted patients and in 12 of 15 patients treated with chemotherapy alone, six of whom received allogeneic SCT in CR2. Age >= 35yr influenced OS negatively in univariate analysis (HR 5.1, 95% CI: 1.55-16.7). Conclusions Hyper-CVAD treatment resulted in a high CR rate and appeared safe, but it showed poor efficacy at preventing relapse. Therefore, this treatment is no longer recommended for adults with T-ALL in Sweden.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Hematologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Hematology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Allmänmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- General Practice (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- antineoplastic combined chemotherapy protocols
- treatment outcome
- precursor T-cell lymphoblastic leukemia-lymphoma
- stem cell
- transplantation
- antineoplastic combined chemotherapy protocols; treatment outcome; precursor T-cell lymphoblastic leukemia-lymphoma; stem cell transplantation
- MEDICINE
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Kozlowski, Piotr ...
-
Åström, Maria, 1 ...
-
Ahlberg, Lucia
-
Bernell, Per
-
Hulegardh, Erik
-
Hägglund, Hans
-
visa fler...
-
Karlsson, Karin
-
Markuszewska-Kuc ...
-
Tomaszewska-Topo ...
-
Smedmyr, Bengt
-
Amini, Rose-Mari ...
-
Hallböök, Helene
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Hematologi
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Allmänmedicin
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Lunds universitet
-
Örebro universitet
-
Karolinska Institutet
-
Umeå universitet
-
Uppsala universitet
-
Linköpings universitet